Deep Sleep Brain Waves May Shield Against Alzheimer's Progression
New Australian-led research suggests that stronger brain wave activity during deep sleep could help protect against the worst effects of Alzheimer's disease, even when a key chemical messenger is elevated. The findings, published in the journal Neurology, point to a possible avenue for slowing cognitive decline.
What did the study examine?
Researchers recruited 60 people recently diagnosed with mild to moderate Alzheimer's disease, all aged 60 and over. None were taking medications known to interfere with brain wave activity. Each participant underwent an overnight sleep study, and the next morning researchers collected cerebrospinal fluid (CSF) samples to measure levels of a chemical called orexin.
Orexin regulates sleep and wakefulness. In type 1 narcolepsy, for instance, a lack of orexin contributes to excessive sleepiness and sudden muscle weakness. Scientists have suspected orexin may play a role in Alzheimer's, particularly because drugs that target orexin already exist.
How does orexin relate to Alzheimer's?
Several small studies have suggested people with Alzheimer's may have dysregulated orexin levels. The theory is that orexin drugs could help the brain clear amyloid beta and tau proteins, which accumulate more when sleep is disrupted. If so, such drugs might slow disease progression.
However, the relationship remains unclear. As the study authors note, few studies have examined whether orexinergic activity relates to cognitive decline or neuropsychiatric symptom severity in people with Alzheimer's disease.
What did the results show?
Higher orexin levels in CSF were correlated with worse disease progression over the following three years. But participants with stronger sleep spindle and slow oscillation activity during non-rapid eye movement (NREM) sleep showed a weaker link between high orexin and poor outcomes.
In healthy brains, these electrical signals help consolidate memories and stabilise the cortical network. People with Alzheimer's often have disturbed sleep, and these signals tend to reflect that disruption. Notably, participants with lower CSF orexin levels had denser spindles and longer slow oscillations.
The study also found orexin was significantly more concentrated in the CSF of women than men.
What are the study's limitations?
This was a small study with only 60 participants and no control group. It also relied on a single overnight sleep study and one CSF sample, which may not represent typical sleep patterns. As most people know, any given night of sleep can differ greatly, especially when connected to unfamiliar equipment.
The authors acknowledge these results are a starting point. Future research with larger cohorts, more detailed baseline sleep data, and cognitively healthy controls would be necessary to confirm the findings.
What does this mean for Alzheimer's treatment?
While the findings are preliminary, they suggest that strengthening deep sleep brain activity could offer some protection against Alzheimer's progression, even when orexin levels are high. This aligns with broader research linking sleep quality to brain health.
For Australians, where an estimated 400,000 people live with dementia, the potential for sleep-based interventions is significant. The study adds to a growing body of evidence that prioritising deep sleep may be a practical, low-cost strategy for brain health.
The research was published in Neurology.
Frequently asked questions
Can deep sleep really protect against Alzheimer's?
This study suggests stronger sleep spindle and slow oscillation activity during deep sleep may weaken the association between high orexin levels and worse Alzheimer's progression. However, the findings are preliminary and require confirmation in larger studies.
What is orexin and why does it matter?
Orexin is a peptide neurotransmitter that regulates sleep and wakefulness. Dysregulated orexin signalling has been linked to apathy, depression, and anxiety, and may contribute to neuropsychiatric symptoms in dementia.
Are there drugs that target orexin?
Yes, drugs that act on orexin already exist, primarily for insomnia and narcolepsy. Researchers are curious whether these could help in Alzheimer's treatment, potentially by helping the brain clear amyloid beta and tau proteins.